LEAP2 ameliorates high fat diet-impaired glucose tolerance and enhances glucose-stimulated insulin secretion from β cells through PPARγ signal pathway

  • Chin Med J (Engl). 2024 Aug 19;137(18):2266-2268. doi: 10.1097/CM9.0000000000003215.
Jiaxi Li  1  2 Mei Li  1 Hao Ke  1 Yang Han  1 Yanhong Huang  1 Yan Zhou  1 Ziqiang Luo  1  3 Chen Chen  4 Dandan Feng  1  3
Affiliations
  • 1. Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China.
  • 2. Department of Biochemistry and Molecular Biology, Key Laboratory of Metabolism and Molecular Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • 3. Hunan Key Laboratory of Organ Fibrosis, Central South University, Changsha, Hunan 410013, China.
  • 4. School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • 99.98%, PPARγ Antagonist
    target: PPAR
    Research Areas: Cancer